Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The type 2 diabetes market was valued at USD 37.94 Billion in 2025. It is poised to grow at a CAGR of 8.40% during the forecast period of 2026-2035, and reach USD 84.99 Billion by 2035. The market growth is driven by rising obesity rates, sedentary lifestyles, aging populations, and increasing prevalence of metabolic disorders, along with advancements in antidiabetic therapies and improved disease awareness globally.
Latest News on Type 2 Diabetes Market (2026)
- The International Diabetes Federation Diabetes Atlas reported 537 million adults living with diabetes globally, with nearly 90% comprising type 2 diabetes, projected to reach 643 million by 2030.
- In April 2026, Eli Lilly reported strong early U.S. prescription uptake for its newly launched oral GLP-1 therapy Foundayo following FDA approval on April 1, 2026, with over 1,390 prescriptions recorded in its first week, reflecting rapid physician acceptance and reinforcing its role in improving adherence.
- In March 2026, Dr. Reddy’s Laboratories launched Obeda, a semaglutide injection for type 2 diabetes after receiving regulatory approval from India’s DCGI, marking the first generic version of semaglutide in the country and significantly improving affordability and access to advanced GLP-1-based therapies in emerging markets.
Key Market Trends and Insights
- By drug class, the injectable segment is expected to account for the largest revenue share, at over 32% in the historical period.
- By route of administration, the oral segment is anticipated to dominate, with an estimated share of about 57% in the historical period.
- By country, the United States is projected to lead the market, holding approximately 39% revenue share in the historical period.
Market Size and Forecast
- Market Size (2025): USD 37.94 Billion
- Projected Market Size (2035): USD 84.99 Billion
- CAGR (2026-2035): 8.40%
Compound Annual Growth Rate
8.4%
Value in USD Billion
2026-2035
Read more about this report - Request a Free Sample
Type 2 Diabetes Market Overview
Type 2 Diabetes is growing rapidly, driven by rising global prevalence of obesity, sedentary lifestyles and aging populations. Advancements in oral antidiabetic drugs, insulin therapies, and combination treatments are improving glycemic control outcomes. Increasing screening programs and public health initiatives support early detection and management. However, lifestyle adherence challenges and complications remain key barriers to optimal control globally especially urban. The market reached a value of approximately USD 37.94 Billion in 2025.
Type 2 Diabetes Market Growth Drivers
Increasing Global Type 2 Diabetes Burden Driving Market Demand
Rising sedentary lifestyles and increasing obesity prevalence are intensifying the global metabolic disease burden and expanding the type 2 diabetes patient pool. This is strengthening long-term demand for effective glycemic control therapies. The International Diabetes Federation Diabetes Atlas reported approximately 589 million adults living with diabetes worldwide, with type 2 diabetes accounting for nearly 90% of cases, reinforcing sustained clinical and commercial demand for therapies supporting HbA1c reduction and long-term metabolic control.
Type 2 Diabetes Market Trends
Key trends shaping the market include GLP-1 adoption, digital glucose monitoring, combination therapies, and increasing focus on personalized diabetes management.
Increasing Innovation in Diabetes Therapies Supporting the Market Expansion
Increasing demand for next-generation oral and injectable incretin therapies, along with rising physician adoption of GLP-1-based regimens, is reshaping competitive dynamics in type 2 diabetes management and accelerating treatment innovation. For instance, in April 2026, Eli Lilly announced strong early U.S. prescription uptake for its newly launched oral GLP-1 therapy Foundayo following FDA approval on April 1, 2026, with over 1,390 prescriptions recorded in its first week, reflecting rapid physician acceptance and reinforcing the expanding role of GLP-1-based oral therapies in improving adherence and strengthening the dominance of the GLP-1 agonist class in modern diabetes care.
Type 2 Diabetes Market Segmentation
Market Breakup by Drug Class
- Insulin
- DPP-4 Inhibitors
- GLP-1 Receptor Agonists
- SGLT2 Inhibitors
- Others
Market Breakup by Route of Administration
- Oral
- Injectable
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Breakup by Country
- United States
- United Kingdom
- Germany
- France
- Italy
- Spain
- Japan
- India
Type 2 Diabetes Market Share
Oral Segment Expected to Lead the Market Segment by Route of Administration
The oral segment is expected to account for the largest revenue share of about 57% in the forecast period. This segment is likely to dominate due to the strong adoption of first-line therapies and ease of administration. The presence of metformin, a widely prescribed oral agent, further supports market stability and long-term therapeutic preference.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Read more about this report - Request a Free Sample
Type 2 Diabetes Market Analysis by Region
The United States is likely to dominate with a market share of around 39% in the forecast period. This dominance is supported by advanced healthcare infrastructure, high diagnosis rates, and strong adoption of innovative therapies. Extensive focus on cardiovascular outcome trial evidence further strengthens treatment decision-making and improves long-term clinical outcomes globally.
Leading Players in the Type 2 Diabetes Market
The key features of the market report comprise patent analysis, clinical trial analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Novo Nordisk A/S
Novo Nordisk A/S is a Denmark-based global pharmaceutical company headquartered in Bagsværd, Denmark, and established in 1923. It specializes in diabetes care, obesity treatment, and rare diseases. Its portfolio includes insulin therapies and GLP-1 receptor agonists such as Ozempic and Wegovy. The company is a global leader in metabolic disease management.
Sanofi S.A.
Sanofi S.A. is a France-based multinational pharmaceutical company headquartered in Paris, established in 2004 following a merger of several firms. It focuses on diabetes care, vaccines, rare diseases, and immunology. Its portfolio includes insulin products and specialty therapeutics. Sanofi maintains a strong global presence across chronic and preventive healthcare markets worldwide.
Takeda Pharmaceutical Company Limited
This is a global biopharmaceutical company engaged in developing innovative therapies across metabolic disorders, gastroenterology, oncology, and rare diseases. In the type 2 diabetes market, the company focuses on advancing treatment approaches through strategic research initiatives and collaborations aimed at improving glycemic control and long-term patient outcomes. Takeda’s expanding metabolic disease portfolio and strong global presence continue to support its position in the market.
Merck & Co., Inc.
Merck & Co., Inc. is a US-based pharmaceutical company headquartered in Rahway, New Jersey, established in 1891. It specializes in oncology, vaccines, infectious diseases, and cardiometabolic therapies. Its leading product, Keytruda, is a major cancer immunotherapy. The company is recognized for strong research capabilities and a diversified global pharmaceutical portfolio.
Other key players in the market are Boehringer Ingelheim International GmbH, Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Daiichi Sankyo Co., Ltd., and Novartis AG.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Key Questions Answered in the Type 2 Diabetes Market Report
- What was the type 2 diabetes market value in 2025?
- What is the type 2 diabetes market forecast outlook for 2026-2035?
- What major factors aid the demand for type 2 diabetes market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major type 2 diabetes market trends?
- Which drug class is expected to dominate the market segment?
- Which route of administration is expected to dominate the market segment?
- Which distribution channel is expected to dominate the market segment?
- Who are the key players in the type 2 diabetes market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
